Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Bonds: Convertible Notes, Sold Out, 2022 Q1

CITADEL ADVISORS LLC historic quarter change: USA Bonds: Convertible Notes, Sold out

In convertible notes that pay a coupon (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,005 positions, added to 266, reduced 334 and sold out of 965.

  • Q1 2022: Stock ATLAS AIR WORLDWIDE HLDGS IN; Country of operation —; Class NOTE 1.875% 6/0; Principal before $72,819,000.
  • Q1 2022: Stock EXACT SCIENCES CORP; Country of operation —; Class NOTE 0.375% 3/0; Principal before $104,450,000.
  • Q1 2022: Stock GLAUKOS CORP; Country of operation —; Class NOTE 2.750% 6/1; Principal before $85,197,000.
  • Q1 2022: Stock TIMKENSTEEL CORPORATION; Country of operation —; Class NOTE 6.000%12/0; Principal before $25,200,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassPrincipal beforePrincipal afterShare changeValue beforeValue afterValue changeFiled
Q1 2022ATLAS AIR WORLDWIDE HLDGS IN
CUSIP 049164BJ4
—NOTE 1.875% 6/0$72,819,000$0-72,819,000$118,627$0-$118,6272022-05-16
Q1 2022EXACT SCIENCES CORP
CUSIP 30063PAC9
—NOTE 0.375% 3/0$104,450,000$0-104,450,000$101,714$0-$101,7142022-05-16
Q1 2022GLAUKOS CORP
CUSIP 377322AB8
—NOTE 2.750% 6/1$85,197,000$0-85,197,000$101,053$0-$101,0532022-05-16
Q1 2022TIMKENSTEEL CORPORATION
CUSIP 887399AB9
—NOTE 6.000%12/0$25,200,000$0-25,200,000$58,248$0-$58,2482022-05-16
Q1 2022BRIDGEBIO PHARMA INC
CUSIP 10806XAB8
United StatesNOTE 2.500% 3/1$73,950,000$0-73,950,000$54,361$0-$54,3612022-05-16
Q1 2022WAYFAIR INC
CUSIP 94419LAF8
—NOTE 1.000% 8/1$33,500,000$0-33,500,000$50,466$0-$50,4662022-05-16
Q1 2022ZILLOW GROUP INC
CUSIP 98954MAH4
—NOTE 2.750% 5/1$39,000,000$0-39,000,000$50,236$0-$50,2362022-05-16
Q1 2022HERCULES CAPITAL INC
CUSIP 427096AF9
—DBCV 4.375% 2/0$38,525,000$0-38,525,000$39,790$0-$39,7902022-05-16
Q1 2022INVITAE CORP
CUSIP 46185LAB9
—NOTE 2.000% 9/0$32,500,000$0-32,500,000$30,642$0-$30,6422022-05-16
Q1 2022ZOGENIX INC
CUSIP 98978LAB1
—NOTE 2.750%10/0$29,500,000$0-29,500,000$29,500$0-$29,5002022-05-16
Q1 20221LIFE HEALTHCARE INC
CUSIP 68269GAB3
—NOTE 3.000% 6/1$32,250,000$0-32,250,000$29,367$0-$29,3672022-05-16
Q1 2022KARYOPHARM THERAPEUTICS INC
CUSIP 48576UAA4
—NOTE 3.000%10/1$29,800,000$0-29,800,000$23,822$0-$23,8222022-05-16
Q1 2022ENCORE CAP EUROPE FIN LTD
CUSIP 29260UAA5
—NOTE 4.500% 9/0$13,750,000$0-13,750,000$20,524$0-$20,5242022-05-16
Q1 2022NEOGENOMICS INC
CUSIP 64049MAB6
—NOTE 0.250% 1/1$23,500,000$0-23,500,000$20,128$0-$20,1282022-05-16
Q1 2022ENCORE CAP GROUP INC
CUSIP 292554AK8
—NOTE 3.250% 3/1$14,500,000$0-14,500,000$19,882$0-$19,8822022-05-16
Q1 2022VAREX IMAGING CORP
CUSIP 92214XAB2
—NOTE 4.000% 6/0$11,872,000$0-11,872,000$19,817$0-$19,8172022-05-16
Q1 2022NOVAVAX INC
CUSIP 670002AB0
—NOTE 3.750% 2/0$11,000,000$0-11,000,000$14,962$0-$14,9622022-05-16
Q1 2022HERITAGE INSURANCE HLDGS INC
CUSIP 42727JAB8
—NOTE 5.875% 8/0$10,663,000$0-10,663,000$10,236$0-$10,2362022-05-16
Q1 2022INNOVIVA INC
CUSIP 45781MAB7
—NOTE 2.500% 8/1$7,095,000$0-7,095,000$8,676$0-$8,6762022-05-16
Q1 2022FIVE9 INC
CUSIP 338307AD3
—NOTE 0.500% 6/0$5,000,000$0-5,000,000$6,147$0-$6,1472022-05-16
Q1 20228X8 INC NEW
CUSIP 282914AB6
—NOTE 0.500% 2/0$5,000,000$0-5,000,000$5,014$0-$5,0142022-05-16
Q1 2022ZYNGA INC
CUSIP 98986TAB4
—NOTE 0.250% 6/0$3,490,000$0-3,490,000$3,770$0-$3,7702022-05-16
Q1 2022ENCORE CAP GROUP INC
CUSIP 292554AM4
—NOTE 3.250%10/0$2,000,000$0-2,000,000$3,288$0-$3,2882022-05-16
Q1 2022NEUROCRINE BIOSCIENCES INC
CUSIP 64125CAD1
—NOTE 2.250% 5/1$2,000,000$0-2,000,000$2,512$0-$2,5122022-05-16
Q1 2022NEOGENOMICS INC
CUSIP 64049MAA8
—NOTE 1.250% 5/0$1,500,000$0-1,500,000$1,783$0-$1,7832022-05-16
Q1 2022ETSY INC
CUSIP 29786AAL0
—NOTE 0.125% 9/0$1,000,000$0-1,000,000$1,344$0-$1,3442022-05-16
Q1 2022NRG ENERGY INC
CUSIP 629377CG5
—DBCV 2.750% 6/0$1,000,000$0-1,000,000$1,185$0-$1,1852022-05-16
Q1 2022INSMED INC
CUSIP 457669AA7
—NOTE 1.750% 1/1$500,000$0-500,000$513$0-$5132022-05-16